Stay updated on CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a new version of the page.
    Difference
    0.0%
    Check dated 2026-06-09T01:31:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a new version of the page. This update is at the metadata level and does not modify the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-18T13:34:20.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:46:59.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Squamous cell carcinoma of the head and neck to the conditions and included the Genetic and Rare Diseases Information Center as a new resource.
    Difference
    0.1%
    Check dated 2026-03-29T13:00:22.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:51:08.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:29:57.000Z thumbnail image

Stay in the know with updates to CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CIMAvax, Nivolumab & Pembrolizumab in Advanced Cancer Clinical Trial page.